Ionis Pharmaceuticals, Inc. (IONS)
USD 27.15
(-4.8%)
USD 27.15
(-4.8%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.4 Billion USD | 4.12% |
| 2022 | 1.34 Billion USD | 15.85% |
| 2021 | 1.16 Billion USD | 55.01% |
| 2020 | 749 Million USD | 5.49% |
| 2019 | 710 Million USD | 24.95% |
| 2018 | 568.21 Million USD | 6.58% |
| 2017 | 533.11 Million USD | 6.49% |
| 2016 | 500.63 Million USD | 25.92% |
| 2015 | 397.57 Million USD | 5.88% |
| 2014 | 375.5 Million USD | 149.78% |
| 2013 | 150.33 Million USD | 4.41% |
| 2012 | 143.99 Million USD | -33.17% |
| 2011 | 215.45 Million USD | 44.83% |
| 2010 | 148.76 Million USD | 1196.06% |
| 2009 | 11.47 Million USD | -93.34% |
| 2008 | 172.43 Million USD | 5.88% |
| 2007 | 162.86 Million USD | 22.62% |
| 2006 | 132.82 Million USD | -5.07% |
| 2005 | 139.91 Million USD | -40.87% |
| 2004 | 236.61 Million USD | 10.88% |
| 2003 | 213.39 Million USD | 2.96% |
| 2002 | 207.25 Million USD | 64.87% |
| 2001 | 125.71 Million USD | 22.94% |
| 2000 | 102.25 Million USD | 17.13% |
| 1999 | 87.3 Million USD | 12.36% |
| 1998 | 77.7 Million USD | 37.52% |
| 1997 | 56.5 Million USD | 183.92% |
| 1996 | 19.9 Million USD | 323.4% |
| 1995 | 4.7 Million USD | -49.46% |
| 1994 | 9.3 Million USD | 5.68% |
| 1993 | 8.8 Million USD | 31.34% |
| 1992 | 6.7 Million USD | 34.0% |
| 1991 | 5 Million USD | 455.56% |
| 1990 | 900 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.76 Billion USD | 0.58% |
| 2024 Q1 | 1.75 Billion USD | 0.73% |
| 2023 Q3 | 1.4 Billion USD | -4.75% |
| 2023 Q2 | 1.47 Billion USD | 8.3% |
| 2023 Q1 | 1.36 Billion USD | 1.19% |
| 2023 FY | 1.4 Billion USD | 4.12% |
| 2023 Q4 | 1.4 Billion USD | -0.26% |
| 2022 Q4 | 1.34 Billion USD | 9.85% |
| 2022 Q3 | 1.22 Billion USD | 0.09% |
| 2022 Q1 | 1.22 Billion USD | 5.27% |
| 2022 FY | 1.34 Billion USD | 15.85% |
| 2022 Q2 | 1.22 Billion USD | 0.09% |
| 2021 FY | 1.16 Billion USD | 55.01% |
| 2021 Q2 | 1.21 Billion USD | 43.71% |
| 2021 Q1 | 847.97 Million USD | 13.21% |
| 2021 Q4 | 1.16 Billion USD | -4.84% |
| 2021 Q3 | 1.22 Billion USD | 0.12% |
| 2020 FY | 749 Million USD | 5.49% |
| 2020 Q4 | 749 Million USD | -6.25% |
| 2020 Q2 | 789.18 Million USD | 1.23% |
| 2020 Q1 | 779.59 Million USD | 9.8% |
| 2020 Q3 | 798.93 Million USD | 1.24% |
| 2019 Q4 | 710 Million USD | 8.19% |
| 2019 Q1 | 637.27 Million USD | 12.15% |
| 2019 Q2 | 587 Million USD | -7.89% |
| 2019 FY | 710 Million USD | 24.95% |
| 2019 Q3 | 656.25 Million USD | 11.8% |
| 2018 Q4 | 568.21 Million USD | -8.21% |
| 2018 Q3 | 619 Million USD | 1.45% |
| 2018 Q1 | 541.63 Million USD | 1.6% |
| 2018 FY | 568.21 Million USD | 6.58% |
| 2018 Q2 | 610.13 Million USD | 12.65% |
| 2017 Q4 | 533.11 Million USD | -8.79% |
| 2017 Q1 | 580.8 Million USD | 16.01% |
| 2017 FY | 533.11 Million USD | 6.49% |
| 2017 Q3 | 584.49 Million USD | 13.16% |
| 2017 Q2 | 516.53 Million USD | -11.07% |
| 2016 FY | 500.63 Million USD | 25.92% |
| 2016 Q1 | 395.45 Million USD | -0.53% |
| 2016 Q2 | 473.95 Million USD | 19.85% |
| 2016 Q3 | 480.33 Million USD | 1.34% |
| 2016 Q4 | 500.63 Million USD | 4.23% |
| 2015 Q3 | 463.98 Million USD | 20.1% |
| 2015 Q1 | 452.7 Million USD | 20.56% |
| 2015 Q4 | 397.57 Million USD | -14.31% |
| 2015 Q2 | 386.31 Million USD | -14.66% |
| 2015 FY | 397.57 Million USD | 5.88% |
| 2014 Q3 | 227.05 Million USD | 0.82% |
| 2014 Q4 | 375.5 Million USD | 65.38% |
| 2014 FY | 375.5 Million USD | 149.78% |
| 2014 Q2 | 225.2 Million USD | 0.81% |
| 2014 Q1 | 223.4 Million USD | 48.6% |
| 2013 Q3 | 219.8 Million USD | 0.82% |
| 2013 Q4 | 150.33 Million USD | -31.6% |
| 2013 Q1 | 216.26 Million USD | 50.19% |
| 2013 FY | 150.33 Million USD | 4.41% |
| 2013 Q2 | 218 Million USD | 0.81% |
| 2012 Q3 | 221.27 Million USD | -1.98% |
| 2012 FY | 143.99 Million USD | -33.17% |
| 2012 Q4 | 143.99 Million USD | -34.93% |
| 2012 Q1 | 217.35 Million USD | 0.89% |
| 2012 Q2 | 225.73 Million USD | 3.86% |
| 2011 Q3 | 212.85 Million USD | 5.76% |
| 2011 Q2 | 201.26 Million USD | 34.13% |
| 2011 Q1 | 150.04 Million USD | 0.87% |
| 2011 FY | 215.45 Million USD | 44.83% |
| 2011 Q4 | 215.45 Million USD | 1.22% |
| 2010 Q1 | 141.6 Million USD | 1133.73% |
| 2010 FY | 148.76 Million USD | 1196.06% |
| 2010 Q4 | 148.76 Million USD | 2.36% |
| 2010 Q2 | 144.67 Million USD | 2.17% |
| 2010 Q3 | 145.33 Million USD | 0.46% |
| 2009 FY | 11.47 Million USD | -93.34% |
| 2009 Q2 | 132.1 Million USD | 0.78% |
| 2009 Q3 | 12.53 Million USD | -90.51% |
| 2009 Q4 | 11.47 Million USD | -8.41% |
| 2009 Q1 | 131.08 Million USD | -23.98% |
| 2008 Q1 | 162.89 Million USD | 0.02% |
| 2008 Q4 | 172.43 Million USD | 2.66% |
| 2008 Q3 | 167.97 Million USD | 0.04% |
| 2008 Q2 | 167.91 Million USD | 3.08% |
| 2008 FY | 172.43 Million USD | 5.88% |
| 2007 FY | 162.86 Million USD | 22.62% |
| 2007 Q1 | 168.38 Million USD | 26.78% |
| 2007 Q2 | 166.55 Million USD | -1.09% |
| 2007 Q3 | 164.72 Million USD | -1.1% |
| 2007 Q4 | 162.86 Million USD | -1.13% |
| 2006 Q2 | 136.17 Million USD | -1.28% |
| 2006 FY | 132.82 Million USD | -5.07% |
| 2006 Q4 | 132.82 Million USD | -1.42% |
| 2006 Q3 | 134.73 Million USD | -1.06% |
| 2006 Q1 | 137.94 Million USD | -1.41% |
| 2005 Q1 | 243.35 Million USD | 2.85% |
| 2005 Q3 | 141.84 Million USD | -41.97% |
| 2005 Q4 | 139.91 Million USD | -1.36% |
| 2005 Q2 | 244.43 Million USD | 0.44% |
| 2005 FY | 139.91 Million USD | -40.87% |
| 2004 Q3 | 229.36 Million USD | 2.38% |
| 2004 Q4 | 236.61 Million USD | 3.16% |
| 2004 Q1 | 219.55 Million USD | 2.89% |
| 2004 FY | 236.61 Million USD | 10.88% |
| 2004 Q2 | 224.03 Million USD | 2.04% |
| 2003 Q4 | 213.39 Million USD | 12.68% |
| 2003 FY | 213.39 Million USD | 2.96% |
| 2003 Q3 | 189.39 Million USD | -0.44% |
| 2003 Q2 | 190.22 Million USD | -4.87% |
| 2003 Q1 | 199.95 Million USD | -3.52% |
| 2002 Q2 | 191.66 Million USD | 43.11% |
| 2002 Q4 | 207.25 Million USD | 15.89% |
| 2002 FY | 207.25 Million USD | 64.87% |
| 2002 Q1 | 133.92 Million USD | 6.53% |
| 2002 Q3 | 178.84 Million USD | -6.69% |
| 2001 Q4 | 125.71 Million USD | 1.67% |
| 2001 FY | 125.71 Million USD | 22.94% |
| 2001 Q3 | 123.65 Million USD | 6.9% |
| 2001 Q2 | 115.66 Million USD | 10.73% |
| 2001 Q1 | 104.45 Million USD | 2.15% |
| 2000 Q1 | 91.29 Million USD | 4.58% |
| 2000 FY | 102.25 Million USD | 17.13% |
| 2000 Q2 | 94.5 Million USD | 3.51% |
| 2000 Q3 | 96.33 Million USD | 1.93% |
| 2000 Q4 | 102.25 Million USD | 6.15% |
| 1999 Q3 | 85.8 Million USD | 4.25% |
| 1999 Q2 | 82.3 Million USD | 4.31% |
| 1999 Q4 | 87.3 Million USD | 1.75% |
| 1999 Q1 | 78.9 Million USD | 1.54% |
| 1999 FY | 87.3 Million USD | 12.36% |
| 1998 Q1 | 56.7 Million USD | 0.35% |
| 1998 Q4 | 77.7 Million USD | 5.14% |
| 1998 Q3 | 73.9 Million USD | 2.78% |
| 1998 FY | 77.7 Million USD | 37.52% |
| 1998 Q2 | 71.9 Million USD | 26.81% |
| 1997 Q1 | 19.8 Million USD | -0.5% |
| 1997 Q3 | 34.1 Million USD | 1.79% |
| 1997 FY | 56.5 Million USD | 183.92% |
| 1997 Q4 | 56.5 Million USD | 65.69% |
| 1997 Q2 | 33.5 Million USD | 69.19% |
| 1996 Q3 | 5 Million USD | 2.04% |
| 1996 Q2 | 4.9 Million USD | -7.55% |
| 1996 FY | 19.9 Million USD | 323.4% |
| 1996 Q1 | 5.3 Million USD | 12.77% |
| 1996 Q4 | 19.9 Million USD | 298.0% |
| 1995 Q4 | 4.7 Million USD | -41.25% |
| 1995 Q2 | 8.4 Million USD | -5.62% |
| 1995 Q3 | 8 Million USD | -4.76% |
| 1995 Q1 | 8.9 Million USD | -4.3% |
| 1995 FY | 4.7 Million USD | -49.46% |
| 1994 Q1 | 8.4 Million USD | -4.55% |
| 1994 FY | 9.3 Million USD | 5.68% |
| 1994 Q4 | 9.3 Million USD | -4.12% |
| 1994 Q2 | 8 Million USD | -4.76% |
| 1994 Q3 | 9.7 Million USD | 21.25% |
| 1993 Q2 | 7.1 Million USD | 7.58% |
| 1993 FY | 8.8 Million USD | 31.34% |
| 1993 Q3 | 8.2 Million USD | 15.49% |
| 1993 Q4 | 8.8 Million USD | 7.32% |
| 1993 Q1 | 6.6 Million USD | -1.49% |
| 1992 Q2 | 6.7 Million USD | 19.64% |
| 1992 FY | 6.7 Million USD | 34.0% |
| 1992 Q1 | 5.6 Million USD | 12.0% |
| 1992 Q3 | 6.8 Million USD | 1.49% |
| 1992 Q4 | 6.7 Million USD | -1.47% |
| 1991 FY | 5 Million USD | 455.56% |
| 1991 Q3 | 3.1 Million USD | 6.9% |
| 1991 Q4 | 5 Million USD | 61.29% |
| 1991 Q1 | 1 Million USD | 11.11% |
| 1991 Q2 | 2.9 Million USD | 190.0% |
| 1990 Q4 | 900 Thousand USD | 0.0% |
| 1990 FY | 900 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -1866.213% |
| Alkermes plc | 287.73 Million USD | -386.698% |
| Agenus Inc. | 137.32 Million USD | -919.761% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 40.232% |
| Aptorum Group Limited | 3.05 Million USD | -45686.366% |
| Ardelyx, Inc. | 51.54 Million USD | -2616.697% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -1238.689% |
| Bicycle Therapeutics plc | 40.08 Million USD | -3393.952% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -1292.052% |
| ChromaDex Corporation | 2.57 Million USD | -54283.534% |
| Chimerix, Inc. | 125 Thousand USD | -1120200.8% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -43139.752% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -5305.188% |
| CRISPR Therapeutics AG | 223 Million USD | -527.952% |
| Precision BioSciences, Inc. | 7.72 Million USD | -18032.539% |
| Dyadic International, Inc. | 88.87 Thousand USD | -1575657.849% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -6365245.455% |
| Fortress Biotech, Inc. | 60.85 Million USD | -2201.131% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -2277082.256% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -36742.305% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -1553732.497% |
| Incyte Corporation | 29.16 Million USD | -4702.057% |
| IO Biotech, Inc. | 1.83 Million USD | -76048.777% |
| Jaguar Health, Inc. | 30.99 Million USD | -4418.362% |
| Novavax, Inc. | 168.01 Million USD | -733.478% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -5981.98% |
| Opthea Limited | 200.53 Million USD | -598.317% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -24233.206% |
| ContextLogic Inc. | 6 Million USD | -23239.6% |
| MiMedx Group, Inc. | 48.09 Million USD | -2811.445% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -6867.391% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -3657093.596% |
| NextCure, Inc. | 5.94 Million USD | -23439.687% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -965676.552% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -6233.391% |
| PDS Biotechnology Corporation | 19.5 Million USD | -7079.139% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -1112.657% |
| Pharming Group N.V. | 166.1 Million USD | -743.067% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -22439.45% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -4078.356% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -116017.413% |
| Acelyrin, Inc. | 1.19 Million USD | -117184.422% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -304329.565% |
| Summit Therapeutics Inc. | 103.29 Million USD | -1255.771% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -37055.107% |
| Senti Biosciences, Inc. | 33.53 Million USD | -4075.49% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -29239.535% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -3952.483% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -2221.54% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -89095.924% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -5412.423% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -1242.153% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -191208.197% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -12413.413% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -912.535% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -10320.24% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -9235.84% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -633.442% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -2559.379% |
| Fortress Biotech, Inc. | 60.85 Million USD | -2201.131% |
| Precigen, Inc. | 5.89 Million USD | -23655.318% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -3235.181% |
| AlloVir, Inc. | 16.64 Million USD | -8311.677% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -2029.623% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -1338.348% |
| ImmuCell Corporation | 10.54 Million USD | -13185.675% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -124377.867% |
| Onconetix, Inc. | 118.85 Thousand USD | -1178102.378% |
| PureTech Health plc | 18.25 Million USD | -7573.293% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -1414421.212% |
| Elevation Oncology, Inc. | 30.13 Million USD | -4546.7% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -5293.53% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -3166.259% |
| Innoviva, Inc. | 446.23 Million USD | -213.821% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -168012.365% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -2094891.323% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -576.615% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -1866.931% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -43826.474% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -134810.983% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -6172.4% |
| Aptose Biosciences Inc. | 621 Thousand USD | -225403.382% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -138422.99% |
| Century Therapeutics, Inc. | 46.65 Million USD | -2901.363% |
| Kura Oncology, Inc. | 9.33 Million USD | -14906.172% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -5144.854% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -1014665.217% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -14821.428% |
| Autolus Therapeutics plc | 47.91 Million USD | -2822.686% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -28444.15% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -20575.86% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -971.771% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -17177.927% |
| IGM Biosciences, Inc. | 34.67 Million USD | -3938.925% |
| INmune Bio, Inc. | 397 Thousand USD | -352639.547% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -705.958% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -34440.853% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -952867.356% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -2713.582% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -2466.201% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -2964.75% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -195.832% |
| Verastem, Inc. | 40.08 Million USD | -3393.429% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -31712.267% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -13828.546% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -21243.941% |
| Histogen Inc. | 4.38 Million USD | -31842.883% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -158672.789% |
| Organovo Holdings, Inc. | 888 Thousand USD | -157600.0% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -4567.92% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -33289.986% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -7311.358% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -1749.902% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -1503998.642% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -5305.396% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -524385.393% |
| Amarin Corporation plc | 8.73 Million USD | -15928.11% |
| Mesoblast Limited | 100.48 Million USD | -1293.645% |
| Turnstone Biologics Corp. | 1.18 Million USD | -117677.628% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -1687.813% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -1284648.624% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -1607.588% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -637.257% |
| Better Therapeutics, Inc. | 10.34 Million USD | -13432.818% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -5955.68% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -1405.247% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -108288.235% |
| Gritstone bio, Inc. | 40.14 Million USD | -3388.382% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -77098.236% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -811.745% |
| Insmed Incorporated | 1.19 Billion USD | -17.348% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -21953.165% |
| OmniAb, Inc. | 22.07 Million USD | -6243.719% |
| Alector, Inc. | 30.45 Million USD | -4498.03% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -1279.083% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -17302.461% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -228.268% |
| Aura Biosciences, Inc. | 16.87 Million USD | -8200.984% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -2361.377% |
| Immunic, Inc. | 639 Thousand USD | -219051.174% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -4596.254% |
| Veracyte, Inc. | 7.52 Million USD | -18509.648% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -117.158% |
| FibroGen, Inc. | 89.69 Million USD | -1461.229% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -32189.048% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -1070008.434% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 72.585% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -3784700.0% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -70626.061% |
| TG Therapeutics, Inc. | 100.11 Million USD | -1298.726% |
| Galecto, Inc. | 66 Thousand USD | -2121681.818% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -1029588.235% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 14.214% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -23181.397% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -25847.304% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -77098.236% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -6429.473% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -3730.874% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -270765.764% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -2995.711% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -4480.284% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -3025.7% |
| Vaxxinity, Inc. | 13.26 Million USD | -10459.312% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | -72.616% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -311750.94% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -15833.28% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 48.19% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -443056.962% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -31312.651% |
| Ainos, Inc. | 5.92 Million USD | -23548.784% |
| Pluri Inc. | 29.05 Million USD | -4720.074% |
| Prothena Corporation plc | 10.72 Million USD | -12961.99% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -6954.436% |
| Celularity Inc. | 26.17 Million USD | -5249.643% |
| Rallybio Corporation | 173 Thousand USD | -809365.896% |
| Cue Biopharma, Inc. | 4.2 Million USD | -33226.416% |
| MeiraGTx Holdings plc | 72.11 Million USD | -1841.757% |
| Omeros Corporation | 329.7 Million USD | -324.736% |
| Humacyte, Inc. | 38.6 Million USD | -3527.917% |
| Immunocore Holdings plc | 82.64 Million USD | -1594.468% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -86718.103% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -39049.455% |
| Blueprint Medicines Corporation | 610.96 Million USD | -129.208% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -95947.737% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -1371.153% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -2776.46% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -1440.551% |
| Pulmatrix, Inc. | 8.32 Million USD | -16717.293% |
| Elicio Therapeutics, Inc. | 6 Million USD | -23212.402% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -10717.891% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -1347.462% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -298487.633% |
| Cytokinetics, Incorporated | 607.37 Million USD | -130.563% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -16011.091% |
| Nutriband Inc. | 79.82 Thousand USD | -1754185.571% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -31130.508% |
| Vor Biopharma Inc. | 31.83 Million USD | -4299.548% |
| Roivant Sciences Ltd. | 477.85 Million USD | -193.054% |
| Evogene Ltd. | 10.65 Million USD | -13045.368% |
| ProKidney Corp. | 3.61 Million USD | -38691.579% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -184402.767% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -5319264.886% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 19.32% |
| CorMedix Inc. | 517.01 Thousand USD | -270758.953% |
| BioLineRx Ltd. | 6.62 Million USD | -21028.183% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -3701.444% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -1851.988% |
| Atai Life Sciences N.V. | 15.21 Million USD | -9106.338% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -166138.638% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -549067.059% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -3145.367% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -340906.185% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -102191.892% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -211086.565% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -686.419% |
| Biomea Fusion, Inc. | 7.83 Million USD | -17784.751% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -392.721% |
| Mereo BioPharma Group plc | 5.3 Million USD | -26322.189% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -65033.767% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -238059.184% |
| Absci Corporation | 4.66 Million USD | -29950.987% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -12053.932% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -6070.416% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -13896.762% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -12071.89% |
| Allakos Inc. | 38.21 Million USD | -3564.467% |
| Imunon, Inc. | 1.13 Million USD | -122816.23% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -16128.717% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -167409.091% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -14003660.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -1485.104% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -29638.288% |
| XOMA Corporation | 118.51 Million USD | -1081.572% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -13807.796% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -3676.736% |
| aTyr Pharma, Inc. | 13.76 Million USD | -10071.976% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -17628.523% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -5509.582% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -6830.839% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -9335740.0% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -503288.332% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -9587.926% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 6.595% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -1028280.075% |
| UroGen Pharma Ltd. | 98.55 Million USD | -1320.966% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -839.131% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -7244.501% |
| Entera Bio Ltd. | 256 Thousand USD | -546921.875% |
| GH Research PLC | 631 Thousand USD | -221829.635% |
| Lisata Therapeutics, Inc. | 137.00 USD | -1022172162.774% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -218027.103% |
| Xencor, Inc. | 14.64 Million USD | -9464.103% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -931924.412% |
| Replimune Group, Inc. | 71.99 Million USD | -1845.237% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -933484.0% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -19888.239% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -1028280.075% |
| Portage Biotech Inc. | 7000.00 USD | -20005271.429% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -211086.565% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -97896.921% |
| OncoCyte Corporation | 2.2 Million USD | -63437.931% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -2092981.235% |
| Purple Biotech Ltd. | 163 Thousand USD | -859026.38% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -55141.657% |
| scPharmaceuticals Inc. | 38.81 Million USD | -3508.194% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -5447.362% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -1918223.288% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -75473.448% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -5214.923% |
| Curis, Inc. | 1.48 Million USD | -93948.086% |
| Daré Bioscience, Inc. | 3.91 Million USD | -35681.603% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -200608.885% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -23339500.0% |
| BeiGene, Ltd. | 197.61 Million USD | -608.628% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -153534.229% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -1637.978% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -2598.792% |
| bluebird bio, Inc. | 224.41 Million USD | -524.001% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | -136.113% |
| DBV Technologies S.A. | 4.52 Million USD | -30840.698% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -104405.672% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -14274.625% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -37074.834% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -271.194% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -3166.031% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -81459.464% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -150802.586% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -7917.267% |
| MacroGenics, Inc. | 30.19 Million USD | -4537.621% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -7810.388% |
| Prime Medicine, Inc. | 4.35 Million USD | -32040.831% |
| Aditxt, Inc. | 1.04 Million USD | -134326.116% |
| Adagene Inc. | 13.54 Million USD | -10242.485% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -10094.191% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -169.974% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -8092.687% |
| SciSparc Ltd. | 24 Thousand USD | -5834800.0% |
| Vericel Corporation | 81.85 Million USD | -1610.78% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -1607.425% |
| Generation Bio Co. | 89.77 Million USD | -1459.89% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -6212.265% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -593.946% |
| Invivyd, Inc. | 722 Thousand USD | -193857.895% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -2787.254% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -47896798.824% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -36511.137% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -6088491.304% |
| 2seventy bio, Inc. | 244.01 Million USD | -473.894% |
| ADMA Biologics, Inc. | 130.59 Million USD | -972.313% |
| Clene Inc. | 7.15 Million USD | -19480.201% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -41377.15% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -465.541% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -127091.281% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -532635.815% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -627.015% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -4830.381% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -14428.229% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -1153.997% |
| Evaxion Biotech A/S | 8.48 Million USD | -16396.848% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -1769.037% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -2063.913% |
| Trevena, Inc. | 35.23 Million USD | -3874.615% |
| Surrozen, Inc. | 882 Thousand USD | -158672.789% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -22428.571% |
| Cingulate Inc. | 135.09 Thousand USD | -1036455.415% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -5849.174% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -2829.657% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -777886.667% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -5417.853% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -7931.06% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -149512.821% |
| Statera Biopharma, Inc. | 11.43 Million USD | -12150.537% |
| ImmunityBio, Inc. | 836.95 Million USD | -67.319% |
| Korro Bio, Inc. | 31.21 Million USD | -4386.084% |
| Kineta, Inc. | 150 Thousand USD | -933484.0% |
| BioVie Inc. | 349.89 Thousand USD | -400128.641% |
| Codexis, Inc. | 12.24 Million USD | -11338.177% |
| Celularity Inc. | 26.17 Million USD | -5249.643% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -2844.75% |
| Celcuity Inc. | 37.03 Million USD | -3681.181% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -794011.543% |
| Cibus, Inc. | 17.67 Million USD | -7823.368% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -41343.504% |
| Kodiak Sciences Inc. | 100 Million USD | -1300.376% |
| Annexon, Inc. | 29.19 Million USD | -4697.451% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -2066.859% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -124710.695% |
| Avalo Therapeutics, Inc. | 2 Million USD | -69918.8% |
| Eyenovia, Inc. | 8.95 Million USD | -15534.028% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -2032.801% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -17099.41% |
| Arcellx, Inc. | 50.84 Million USD | -2654.423% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -95947.737% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -6493.728% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -132637.062% |
| Moolec Science SA | 99.04 Thousand USD | -1413764.265% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -4969.969% |
| Geron Corporation | 35.05 Million USD | -3895.253% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -236850.254% |
| Royalty Pharma plc | 6.13 Billion USD | 77.175% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -85184.775% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -4411644.692% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -5949.663% |
| Humacyte, Inc. | 38.6 Million USD | -3527.917% |
| Structure Therapeutics Inc. | 4.01 Million USD | -34795.988% |
| 89bio, Inc. | 24.79 Million USD | -5547.816% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -11162.474% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -74946.945% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -135595.349% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -1307.3% |
| Notable Labs, Ltd. | 1.52 Million USD | -91667.759% |
| Liquidia Corporation | 2.36 Million USD | -59137.563% |
| Mustang Bio, Inc. | 1.97 Million USD | -70697.573% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -10094.191% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -20040.601% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -441658.991% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -2707.659% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -14481.175% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -2138237.736% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -1029588.235% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -22255.939% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -1077112.308% |
| PepGen Inc. | 17.1 Million USD | -8089.333% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -295337.975% |
| United Therapeutics Corporation | 300 Million USD | -366.792% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -5749.279% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -33539.822% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -242179.585% |
| XOMA Corporation | 118.51 Million USD | -1081.572% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -3784700.0% |
| Bionomics Limited | 117.62 Million USD | -1090.512% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -149993.891% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -24862.139% |
| uniQure N.V. | 130.06 Million USD | -976.674% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -2290.128% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -204036.443% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -32189.048% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -101010.181% |
| Altimmune, Inc. | 175 Thousand USD | -800114.857% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -261.054% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -24862.139% |
| Compugen Ltd. | 719 Thousand USD | -194667.177% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -27542.637% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -1556.172% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -14002.477% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -21852.908% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -1431.972% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -14002.477% |
| Instil Bio, Inc. | 81.42 Million USD | -1619.793% |
| argenx SE | 15.35 Million USD | -9020.594% |
| Immunome, Inc. | 1.34 Million USD | -104405.672% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -261164.179% |
| Verona Pharma plc | 48.37 Million USD | -2794.894% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -15095.052% |
| Shattuck Labs, Inc. | 3.4 Million USD | -41014.974% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -1647401.176% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -833457.143% |
| Moolec Science SA | 99.04 Thousand USD | -1413764.265% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -12593.688% |
| AnaptysBio, Inc. | 16.03 Million USD | -8632.157% |
| Design Therapeutics, Inc. | 2.33 Million USD | -59898.972% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -5172874.77% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -23239.6% |
| Achilles Therapeutics plc | 1.07 Million USD | -130046.468% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -15095.052% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -7024257.945% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -8264.233% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -1754185.571% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -18769180.257% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -10772023.077% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -308.89% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -5619.556% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -55915.264% |
| Palisade Bio, Inc. | 90 Thousand USD | -1555873.333% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -721743.299% |
| Beam Therapeutics Inc. | 159.91 Million USD | -775.722% |
| Neurogene Inc. | 13.37 Million USD | -10371.667% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -357.01% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -5232.125% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -2340804.684% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -139937.6% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -3357.036% |
| Athira Pharma, Inc. | 1.21 Million USD | -114967.872% |
| Vaccinex, Inc. | 26 Thousand USD | -5385961.538% |
| HCW Biologics Inc. | 6.3 Million USD | -22112.966% |
| XOMA Corporation | 118.51 Million USD | -1081.572% |
| Nektar Therapeutics | 112.62 Million USD | -1143.397% |
| Arvinas, Inc. | 800 Thousand USD | -174947.0% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -9587.926% |
| Merus N.V. | 10.48 Million USD | -13252.174% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -9307.968% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -10327.999% |
| Rezolute, Inc. | 1.66 Million USD | -84260.0% |
| Clene Inc. | 7.15 Million USD | -19480.201% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -1909121.792% |
| BeyondSpring Inc. | 3.36 Million USD | -41528.3% |
| Synlogic, Inc. | 12.49 Million USD | -11111.08% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -4188.266% |
| Krystal Biotech, Inc. | 6.62 Million USD | -21053.716% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -719.321% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -23255.17% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -2956088.385% |
| MannKind Corporation | 252.15 Million USD | -455.372% |
| Ikena Oncology, Inc. | 7.18 Million USD | -19403.844% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -703606.533% |
| Gossamer Bio, Inc. | 197.4 Million USD | -609.392% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -269203.077% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -397.773% |
| Mural Oncology plc | 8.91 Million USD | -15615.139% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -3101.884% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -97419.22% |
| Champions Oncology, Inc. | 6.09 Million USD | -22883.358% |
| REGENXBIO Inc. | 82.22 Million USD | -1603.165% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -283375.202% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -31482.679% |
| Vaxart, Inc. | 2.62 Million USD | -53288.334% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -515443.513% |
| Cellectis S.A. | 36.24 Million USD | -3764.066% |
| Longeveron Inc. | 1.44 Million USD | -96611.05% |
| Repare Therapeutics Inc. | 1.01 Million USD | -138551.089% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | -23.652% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -3028.004% |
| Revolution Medicines, Inc. | 80.57 Million USD | -1637.978% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -43552.618% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -791072.881% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -1138417.073% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | -93.235% |
| Denali Therapeutics Inc. | 44.98 Million USD | -3013.261% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -11099.2% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -1036455.415% |
| Passage Bio, Inc. | 22.92 Million USD | -6009.576% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -23088.872% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -216341.422% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -6844.587% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -285691.02% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -343586.818% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -117776.768% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -300409.871% |
| OmniAb, Inc. | 22.07 Million USD | -6243.719% |
| Anew Medical, Inc. | 1.54 Million USD | -90833.506% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -4637.404% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -15402.889% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -4404.265% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -34440.853% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -2616.17% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -21894.283% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -9811.36% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -208289.286% |
| Alumis Inc. Common Stock | 30.86 Million USD | -4437.835% |
| Equillium, Inc. | 384 Thousand USD | -364581.25% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -22637.068% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -827.1% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -2764.985% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -1163950.473% |
| Dominari Holdings Inc. | 3.02 Million USD | -46147.556% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -7082163.693% |
| vTv Therapeutics Inc. | 169 Thousand USD | -828524.852% |
| Bio-Techne Corporation | 319 Million USD | -338.989% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -2357.317% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -684.234% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -8989.219% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -11208.859% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -29032.016% |
| Nkarta, Inc. | 82.27 Million USD | -1602.171% |
| BioCardia, Inc. | 982 Thousand USD | -142504.481% |
| Iterum Therapeutics plc | 18.95 Million USD | -7287.508% |